As part of its education program titled, Returning to Practice in the Post-COVID-19 Era: Resources for Treating CLL, the Association of Cancer Care Centers (ACCC) is seeking an oncologist to participate in a 30-minute key informant interview to share their experience with managing patients with CLL in the COVID-19/post-COVID-19 era. ACCC will highlight findings from the interviews in a whitepaper on treating CLL in the pandemic era. The interviewee will receive a $100 honorarium.
If interested, please contact Program Manager, Limaya Atembina at latembina@accc-cancer.org. You may also fill out the Volunteer Registry Form by clicking "Apply Now" below and indicating "CLL Interview" when asked if a specific opportunity interests you.
Apply now

A recent discussion between ACCC and Highlands Oncology centered on how artificial intelligence can be implemented thoughtfully in cancer care to support clinicians and operations without compromising clinical judgement or patient care.

Small Cell SMASHERS was founded in 2023 as a patient-centered advocacy and education community designed to challenge long-standing narratives about small cell lung cancer and restore a sense of voice, connection, and hope for patients and their loved ones.

ACCCBuzz spoke with Fox Chase Cancer Center to learn more about its partnership with Omniscope, a leader in advanced molecular profiling technology, in hopes of developing an assay that accurately predicts which patients will respond well to immunotherapy based on the presence of certain T-cell clones.

On Friday, April 17, ACCC welcomed oncology leaders from around the country to Washington, DC for the inaugural ACCC Leadership Summit, a forum designed for executive-level decision-makers to engage in strategic dialogue, peer-to-peer exchange, and actionable insights at the highest level of oncology leadership.
